
Reliance Life Sciences has
announced that it will buy a controlling share of GeneMedix Plc. UK-based
GeneMedix is a biopharmaceutical company whose core technology involves
"protein development scale-up and manufacture" (see link). Reliance Life Sciences, based in India, "is developing business
opportunities in the domains of medical biotechnology, plant biotechnology,
industrial biotechnology, clinical research services and contract
manufacturing" (see link). Reliance's investment is reported to be $63.2
million.

Jason Derry, Ph.D., who graduated with honors from DePaul University
College of Law, is a molecular biologist and founding author of Patent Docs.

Leave a reply to Donald Zuhn Cancel reply